healthcare

healthcare Articles

he World Health Organization now has upgraded the COVID-19 outbreak to pandemic status, as the cases outside of China have risen exponentially in the past two weeks.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected coronavirus stocks increased.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical stocks decreased.
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
More and more companies are joining the fight against the coronavirus, and 24/7 Wall St. is taking a look at some of the biggest movers on the day tied to COVID-19.
Kala Pharmaceuticals said that it had positive topline results from its late-stage clinical trial for the treatment of dry eye disease.
Challenger, Gray & Christmas warns that a global recession that may have begun on February 21 is picking up speed.
Walmart has 4,769 stores in the United States. It is the nation's largest employer, with over a million U.S. workers. Its stores represent a real threat of the spread of COVID-19.
Canadian cannabis grower CannTrust's headwinds include possible delisting from the New York Stock Exchange, overdue financial reports, a class-action lawsuit, black market competition and more.
Shares of Amarin have plunged in recent months. Even more troubling, there appears to no catalyst to drive them higher.
More and more companies are joining the fight against the coronavirus. Quest Diagnostics is one of the newest to make this list.
Arcturus Therapeutics stock jumped on Wednesday after the company announced that it would be joining the fight against the latest coronavirus.
Stealth Bio stock more than doubled on Tuesday after the company announced a critical update from the FDA.
Co-Diagnostics is a small-cap stock that is far from a household name, but it has received much added exposure of late.